nodes	percent_of_prediction	percent_of_DWPC	metapath
Histamine Phosphate—SLC22A2—Vinblastine—head and neck cancer	0.26	0.393	CbGbCtD
Histamine Phosphate—CYP2D6—Hydroxyurea—head and neck cancer	0.184	0.278	CbGbCtD
Histamine Phosphate—CYP2C9—Fluorouracil—head and neck cancer	0.077	0.116	CbGbCtD
Histamine Phosphate—CYP2D6—Vinblastine—head and neck cancer	0.0653	0.0985	CbGbCtD
Histamine Phosphate—CYP3A4—Vinblastine—head and neck cancer	0.0415	0.0626	CbGbCtD
Histamine Phosphate—CYP3A4—Docetaxel—head and neck cancer	0.0342	0.0516	CbGbCtD
Histamine Phosphate—Poisoning—Hydroxyurea—head and neck cancer	0.0147	0.0491	CcSEcCtD
Histamine Phosphate—Intoxication—Hydroxyurea—head and neck cancer	0.0147	0.0491	CcSEcCtD
Histamine Phosphate—Slurred speech—Fluorouracil—head and neck cancer	0.00637	0.0213	CcSEcCtD
Histamine Phosphate—Risedronate—PTGS2—head and neck cancer	0.00617	1	CrCbGaD
Histamine Phosphate—Numbness—Vinblastine—head and neck cancer	0.00523	0.0175	CcSEcCtD
Histamine Phosphate—Sensory loss—Vinblastine—head and neck cancer	0.00501	0.0167	CcSEcCtD
Histamine Phosphate—HRH1—nose—head and neck cancer	0.00467	0.145	CbGeAlD
Histamine Phosphate—Creatinine increased—Hydroxyurea—head and neck cancer	0.00416	0.0139	CcSEcCtD
Histamine Phosphate—Neoplasm—Vinblastine—head and neck cancer	0.00392	0.0131	CcSEcCtD
Histamine Phosphate—Blood urea increased—Hydroxyurea—head and neck cancer	0.00373	0.0125	CcSEcCtD
Histamine Phosphate—Neoplasm—Hydroxyurea—head and neck cancer	0.00358	0.012	CcSEcCtD
Histamine Phosphate—Tingling sensation—Fluorouracil—head and neck cancer	0.00354	0.0118	CcSEcCtD
Histamine Phosphate—Numbness—Fluorouracil—head and neck cancer	0.00343	0.0115	CcSEcCtD
Histamine Phosphate—Sensory loss—Fluorouracil—head and neck cancer	0.00329	0.011	CcSEcCtD
Histamine Phosphate—Renal failure acute—Hydroxyurea—head and neck cancer	0.00311	0.0104	CcSEcCtD
Histamine Phosphate—Dysarthria—Fluorouracil—head and neck cancer	0.00301	0.0101	CcSEcCtD
Histamine Phosphate—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00269	0.00899	CcSEcCtD
Histamine Phosphate—Swelling—Fluorouracil—head and neck cancer	0.00234	0.00783	CcSEcCtD
Histamine Phosphate—Neutropenia—Hydroxyurea—head and neck cancer	0.00232	0.00776	CcSEcCtD
Histamine Phosphate—Weight increased—Hydroxyurea—head and neck cancer	0.00226	0.00755	CcSEcCtD
Histamine Phosphate—Oliguria—Docetaxel—head and neck cancer	0.00223	0.00746	CcSEcCtD
Histamine Phosphate—Infestation—Hydroxyurea—head and neck cancer	0.00221	0.0074	CcSEcCtD
Histamine Phosphate—Infestation NOS—Hydroxyurea—head and neck cancer	0.00221	0.0074	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Vinblastine—head and neck cancer	0.00217	0.00725	CcSEcCtD
Histamine Phosphate—Stomatitis—Hydroxyurea—head and neck cancer	0.00216	0.00721	CcSEcCtD
Histamine Phosphate—SLC22A3—tongue—head and neck cancer	0.00212	0.066	CbGeAlD
Histamine Phosphate—Injection site reaction—Docetaxel—head and neck cancer	0.00204	0.00683	CcSEcCtD
Histamine Phosphate—Influenza like illness—Docetaxel—head and neck cancer	0.002	0.00667	CcSEcCtD
Histamine Phosphate—Cardiac arrest—Fluorouracil—head and neck cancer	0.00197	0.00657	CcSEcCtD
Histamine Phosphate—Dry skin—Fluorouracil—head and neck cancer	0.00189	0.00633	CcSEcCtD
Histamine Phosphate—Neoplasm—Docetaxel—head and neck cancer	0.00186	0.00621	CcSEcCtD
Histamine Phosphate—HNMT—connective tissue—head and neck cancer	0.00184	0.0571	CbGeAlD
Histamine Phosphate—Muscular weakness—Fluorouracil—head and neck cancer	0.00182	0.0061	CcSEcCtD
Histamine Phosphate—Angiopathy—Hydroxyurea—head and neck cancer	0.0018	0.00603	CcSEcCtD
Histamine Phosphate—Dysphagia—Fluorouracil—head and neck cancer	0.00179	0.00597	CcSEcCtD
Histamine Phosphate—Chills—Hydroxyurea—head and neck cancer	0.00178	0.00596	CcSEcCtD
Histamine Phosphate—Eosinophilia—Fluorouracil—head and neck cancer	0.00177	0.00591	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00176	0.00588	CcSEcCtD
Histamine Phosphate—Anaemia—Vinblastine—head and neck cancer	0.00175	0.00586	CcSEcCtD
Histamine Phosphate—HNMT—epithelium—head and neck cancer	0.00174	0.0542	CbGeAlD
Histamine Phosphate—Erythema—Hydroxyurea—head and neck cancer	0.00173	0.00578	CcSEcCtD
Histamine Phosphate—Malaise—Vinblastine—head and neck cancer	0.00171	0.00572	CcSEcCtD
Histamine Phosphate—Vertigo—Vinblastine—head and neck cancer	0.0017	0.0057	CcSEcCtD
Histamine Phosphate—Leukopenia—Vinblastine—head and neck cancer	0.0017	0.00568	CcSEcCtD
Histamine Phosphate—Swelling—Docetaxel—head and neck cancer	0.00169	0.00565	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00166	0.00555	CcSEcCtD
Histamine Phosphate—Convulsion—Vinblastine—head and neck cancer	0.00164	0.00549	CcSEcCtD
Histamine Phosphate—Hypertension—Vinblastine—head and neck cancer	0.00164	0.00547	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0016	0.00536	CcSEcCtD
Histamine Phosphate—Pneumonia—Fluorouracil—head and neck cancer	0.0016	0.00536	CcSEcCtD
Histamine Phosphate—Anaemia—Hydroxyurea—head and neck cancer	0.0016	0.00534	CcSEcCtD
Histamine Phosphate—Discomfort—Vinblastine—head and neck cancer	0.00159	0.00533	CcSEcCtD
Histamine Phosphate—Hot flush—Docetaxel—head and neck cancer	0.00159	0.00533	CcSEcCtD
Histamine Phosphate—Infestation—Fluorouracil—head and neck cancer	0.00159	0.00533	CcSEcCtD
Histamine Phosphate—Infestation NOS—Fluorouracil—head and neck cancer	0.00159	0.00533	CcSEcCtD
Histamine Phosphate—Menopausal symptoms—Docetaxel—head and neck cancer	0.00158	0.00529	CcSEcCtD
Histamine Phosphate—Renal impairment—Docetaxel—head and neck cancer	0.00157	0.00524	CcSEcCtD
Histamine Phosphate—Malaise—Hydroxyurea—head and neck cancer	0.00156	0.00521	CcSEcCtD
Histamine Phosphate—Stomatitis—Fluorouracil—head and neck cancer	0.00155	0.00519	CcSEcCtD
Histamine Phosphate—Leukopenia—Hydroxyurea—head and neck cancer	0.00155	0.00518	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Vinblastine—head and neck cancer	0.00152	0.00507	CcSEcCtD
Histamine Phosphate—Convulsion—Hydroxyurea—head and neck cancer	0.0015	0.00501	CcSEcCtD
Histamine Phosphate—Pain in extremity—Docetaxel—head and neck cancer	0.00149	0.00499	CcSEcCtD
Histamine Phosphate—Anorexia—Vinblastine—head and neck cancer	0.00147	0.00493	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00146	0.00489	CcSEcCtD
Histamine Phosphate—Discomfort—Hydroxyurea—head and neck cancer	0.00145	0.00486	CcSEcCtD
Histamine Phosphate—SLC22A3—mouth—head and neck cancer	0.00143	0.0444	CbGeAlD
Histamine Phosphate—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00142	0.00476	CcSEcCtD
Histamine Phosphate—Infection—Hydroxyurea—head and neck cancer	0.0014	0.00469	CcSEcCtD
Histamine Phosphate—Paraesthesia—Vinblastine—head and neck cancer	0.00139	0.00465	CcSEcCtD
Histamine Phosphate—Dehydration—Docetaxel—head and neck cancer	0.00139	0.00464	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00138	0.00463	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00138	0.00462	CcSEcCtD
Histamine Phosphate—HRH3—head—head and neck cancer	0.00137	0.0427	CbGeAlD
Histamine Phosphate—Skin disorder—Hydroxyurea—head and neck cancer	0.00137	0.00458	CcSEcCtD
Histamine Phosphate—Dry skin—Docetaxel—head and neck cancer	0.00137	0.00457	CcSEcCtD
Histamine Phosphate—Abdominal pain upper—Docetaxel—head and neck cancer	0.00136	0.00456	CcSEcCtD
Histamine Phosphate—Anorexia—Hydroxyurea—head and neck cancer	0.00135	0.0045	CcSEcCtD
Histamine Phosphate—Decreased appetite—Vinblastine—head and neck cancer	0.00135	0.0045	CcSEcCtD
Histamine Phosphate—Cramp muscle—Docetaxel—head and neck cancer	0.00134	0.00449	CcSEcCtD
Histamine Phosphate—Constipation—Vinblastine—head and neck cancer	0.00132	0.00442	CcSEcCtD
Histamine Phosphate—Pain—Vinblastine—head and neck cancer	0.00132	0.00442	CcSEcCtD
Histamine Phosphate—Dysphagia—Docetaxel—head and neck cancer	0.00129	0.00431	CcSEcCtD
Histamine Phosphate—Arrhythmia—Fluorouracil—head and neck cancer	0.00128	0.00427	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Vinblastine—head and neck cancer	0.00128	0.00426	CcSEcCtD
Histamine Phosphate—Bronchospasm—Docetaxel—head and neck cancer	0.00127	0.00424	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00127	0.00423	CcSEcCtD
Histamine Phosphate—Dyspnoea—Hydroxyurea—head and neck cancer	0.00126	0.00421	CcSEcCtD
Histamine Phosphate—Erythema—Fluorouracil—head and neck cancer	0.00124	0.00416	CcSEcCtD
Histamine Phosphate—Dyspepsia—Hydroxyurea—head and neck cancer	0.00124	0.00415	CcSEcCtD
Histamine Phosphate—Decreased appetite—Hydroxyurea—head and neck cancer	0.00123	0.0041	CcSEcCtD
Histamine Phosphate—Abdominal pain—Vinblastine—head and neck cancer	0.00122	0.00409	CcSEcCtD
Histamine Phosphate—HNMT—thyroid gland—head and neck cancer	0.00122	0.0379	CbGeAlD
Histamine Phosphate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00122	0.00407	CcSEcCtD
Histamine Phosphate—Fatigue—Hydroxyurea—head and neck cancer	0.00122	0.00407	CcSEcCtD
Histamine Phosphate—Pain—Hydroxyurea—head and neck cancer	0.00121	0.00404	CcSEcCtD
Histamine Phosphate—Constipation—Hydroxyurea—head and neck cancer	0.00121	0.00404	CcSEcCtD
Histamine Phosphate—Neutropenia—Docetaxel—head and neck cancer	0.00121	0.00403	CcSEcCtD
Histamine Phosphate—Weight increased—Docetaxel—head and neck cancer	0.00117	0.00392	CcSEcCtD
Histamine Phosphate—Weight decreased—Docetaxel—head and neck cancer	0.00117	0.0039	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00116	0.00389	CcSEcCtD
Histamine Phosphate—Pneumonia—Docetaxel—head and neck cancer	0.00116	0.00387	CcSEcCtD
Histamine Phosphate—Anaemia—Fluorouracil—head and neck cancer	0.00115	0.00385	CcSEcCtD
Histamine Phosphate—Infestation NOS—Docetaxel—head and neck cancer	0.00115	0.00384	CcSEcCtD
Histamine Phosphate—Infestation—Docetaxel—head and neck cancer	0.00115	0.00384	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Vinblastine—head and neck cancer	0.00114	0.00381	CcSEcCtD
Histamine Phosphate—Renal failure—Docetaxel—head and neck cancer	0.00113	0.00378	CcSEcCtD
Histamine Phosphate—Stomatitis—Docetaxel—head and neck cancer	0.00112	0.00375	CcSEcCtD
Histamine Phosphate—Body temperature increased—Hydroxyurea—head and neck cancer	0.00112	0.00373	CcSEcCtD
Histamine Phosphate—Leukopenia—Fluorouracil—head and neck cancer	0.00111	0.00373	CcSEcCtD
Histamine Phosphate—Asthenia—Vinblastine—head and neck cancer	0.00111	0.00371	CcSEcCtD
Histamine Phosphate—CA4—neck—head and neck cancer	0.00109	0.0338	CbGeAlD
Histamine Phosphate—HNMT—head—head and neck cancer	0.00108	0.0336	CbGeAlD
Histamine Phosphate—Convulsion—Fluorouracil—head and neck cancer	0.00108	0.00361	CcSEcCtD
Histamine Phosphate—Chest pain—Fluorouracil—head and neck cancer	0.00106	0.00354	CcSEcCtD
Histamine Phosphate—Myalgia—Fluorouracil—head and neck cancer	0.00106	0.00354	CcSEcCtD
Histamine Phosphate—Diarrhoea—Vinblastine—head and neck cancer	0.00106	0.00354	CcSEcCtD
Histamine Phosphate—Discomfort—Fluorouracil—head and neck cancer	0.00105	0.0035	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00104	0.00348	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Docetaxel—head and neck cancer	0.00103	0.00343	CcSEcCtD
Histamine Phosphate—Confusional state—Fluorouracil—head and neck cancer	0.00102	0.00342	CcSEcCtD
Histamine Phosphate—Dizziness—Vinblastine—head and neck cancer	0.00102	0.00342	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Docetaxel—head and neck cancer	0.00102	0.0034	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00102	0.0034	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Docetaxel—head and neck cancer	0.00101	0.00339	CcSEcCtD
Histamine Phosphate—Asthenia—Hydroxyurea—head and neck cancer	0.00101	0.00339	CcSEcCtD
Histamine Phosphate—Infection—Fluorouracil—head and neck cancer	0.00101	0.00337	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Fluorouracil—head and neck cancer	0.000996	0.00333	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000995	0.00333	CcSEcCtD
Histamine Phosphate—SLC22A3—parotid gland—head and neck cancer	0.000993	0.0309	CbGeAlD
Histamine Phosphate—Tachycardia—Fluorouracil—head and neck cancer	0.000991	0.00332	CcSEcCtD
Histamine Phosphate—Vomiting—Vinblastine—head and neck cancer	0.000984	0.00329	CcSEcCtD
Histamine Phosphate—Headache—Vinblastine—head and neck cancer	0.000969	0.00324	CcSEcCtD
Histamine Phosphate—Anorexia—Fluorouracil—head and neck cancer	0.000968	0.00324	CcSEcCtD
Histamine Phosphate—Diarrhoea—Hydroxyurea—head and neck cancer	0.000966	0.00323	CcSEcCtD
Histamine Phosphate—Flushing—Docetaxel—head and neck cancer	0.000958	0.0032	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Docetaxel—head and neck cancer	0.000958	0.0032	CcSEcCtD
Histamine Phosphate—SLC22A3—saliva-secreting gland—head and neck cancer	0.000951	0.0296	CbGeAlD
Histamine Phosphate—Hypotension—Fluorouracil—head and neck cancer	0.000949	0.00317	CcSEcCtD
Histamine Phosphate—Angiopathy—Docetaxel—head and neck cancer	0.000936	0.00313	CcSEcCtD
Histamine Phosphate—Dizziness—Hydroxyurea—head and neck cancer	0.000933	0.00312	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Docetaxel—head and neck cancer	0.00093	0.00311	CcSEcCtD
Histamine Phosphate—Chills—Docetaxel—head and neck cancer	0.000926	0.0031	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000925	0.00309	CcSEcCtD
Histamine Phosphate—Arrhythmia—Docetaxel—head and neck cancer	0.000922	0.00308	CcSEcCtD
Histamine Phosphate—Nausea—Vinblastine—head and neck cancer	0.000919	0.00307	CcSEcCtD
Histamine Phosphate—Insomnia—Fluorouracil—head and neck cancer	0.000919	0.00307	CcSEcCtD
Histamine Phosphate—Paraesthesia—Fluorouracil—head and neck cancer	0.000912	0.00305	CcSEcCtD
Histamine Phosphate—Dyspnoea—Fluorouracil—head and neck cancer	0.000906	0.00303	CcSEcCtD
Histamine Phosphate—Mental disorder—Docetaxel—head and neck cancer	0.000904	0.00302	CcSEcCtD
Histamine Phosphate—Malnutrition—Docetaxel—head and neck cancer	0.000898	0.003	CcSEcCtD
Histamine Phosphate—Erythema—Docetaxel—head and neck cancer	0.000898	0.003	CcSEcCtD
Histamine Phosphate—Vomiting—Hydroxyurea—head and neck cancer	0.000897	0.003	CcSEcCtD
Histamine Phosphate—Dyspepsia—Fluorouracil—head and neck cancer	0.000894	0.00299	CcSEcCtD
Histamine Phosphate—Rash—Hydroxyurea—head and neck cancer	0.00089	0.00298	CcSEcCtD
Histamine Phosphate—Dermatitis—Hydroxyurea—head and neck cancer	0.000889	0.00297	CcSEcCtD
Histamine Phosphate—CA4—parotid gland—head and neck cancer	0.000885	0.0275	CbGeAlD
Histamine Phosphate—Headache—Hydroxyurea—head and neck cancer	0.000884	0.00296	CcSEcCtD
Histamine Phosphate—Decreased appetite—Fluorouracil—head and neck cancer	0.000883	0.00295	CcSEcCtD
Histamine Phosphate—Dysgeusia—Docetaxel—head and neck cancer	0.00088	0.00294	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000877	0.00293	CcSEcCtD
Histamine Phosphate—SLC22A3—connective tissue—head and neck cancer	0.000874	0.0272	CbGeAlD
Histamine Phosphate—Back pain—Docetaxel—head and neck cancer	0.000869	0.00291	CcSEcCtD
Histamine Phosphate—Pain—Fluorouracil—head and neck cancer	0.000869	0.0029	CcSEcCtD
Histamine Phosphate—Muscle spasms—Docetaxel—head and neck cancer	0.000864	0.00289	CcSEcCtD
Histamine Phosphate—CA4—saliva-secreting gland—head and neck cancer	0.000848	0.0264	CbGeAlD
Histamine Phosphate—Nausea—Hydroxyurea—head and neck cancer	0.000838	0.0028	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Fluorouracil—head and neck cancer	0.000837	0.0028	CcSEcCtD
Histamine Phosphate—HRH2—head—head and neck cancer	0.000836	0.026	CbGeAlD
Histamine Phosphate—Anaemia—Docetaxel—head and neck cancer	0.00083	0.00278	CcSEcCtD
Histamine Phosphate—Urticaria—Fluorouracil—head and neck cancer	0.000807	0.0027	CcSEcCtD
Histamine Phosphate—Leukopenia—Docetaxel—head and neck cancer	0.000804	0.00269	CcSEcCtD
Histamine Phosphate—Body temperature increased—Fluorouracil—head and neck cancer	0.000803	0.00269	CcSEcCtD
Histamine Phosphate—Palpitations—Docetaxel—head and neck cancer	0.000794	0.00265	CcSEcCtD
Histamine Phosphate—Cough—Docetaxel—head and neck cancer	0.000784	0.00262	CcSEcCtD
Histamine Phosphate—Convulsion—Docetaxel—head and neck cancer	0.000778	0.0026	CcSEcCtD
Histamine Phosphate—Hypertension—Docetaxel—head and neck cancer	0.000776	0.00259	CcSEcCtD
Histamine Phosphate—Arthralgia—Docetaxel—head and neck cancer	0.000765	0.00256	CcSEcCtD
Histamine Phosphate—Chest pain—Docetaxel—head and neck cancer	0.000765	0.00256	CcSEcCtD
Histamine Phosphate—Myalgia—Docetaxel—head and neck cancer	0.000765	0.00256	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000759	0.00254	CcSEcCtD
Histamine Phosphate—HNMT—lymph node—head and neck cancer	0.000757	0.0236	CbGeAlD
Histamine Phosphate—Hypersensitivity—Fluorouracil—head and neck cancer	0.000748	0.0025	CcSEcCtD
Histamine Phosphate—Dry mouth—Docetaxel—head and neck cancer	0.000748	0.0025	CcSEcCtD
Histamine Phosphate—Confusional state—Docetaxel—head and neck cancer	0.000739	0.00247	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Docetaxel—head and neck cancer	0.000733	0.00245	CcSEcCtD
Histamine Phosphate—Infection—Docetaxel—head and neck cancer	0.000728	0.00244	CcSEcCtD
Histamine Phosphate—SLC22A5—parotid gland—head and neck cancer	0.000722	0.0225	CbGeAlD
Histamine Phosphate—Shock—Docetaxel—head and neck cancer	0.000721	0.00241	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Docetaxel—head and neck cancer	0.000719	0.0024	CcSEcCtD
Histamine Phosphate—Pruritus—Fluorouracil—head and neck cancer	0.000719	0.0024	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Docetaxel—head and neck cancer	0.000718	0.0024	CcSEcCtD
Histamine Phosphate—Tachycardia—Docetaxel—head and neck cancer	0.000716	0.00239	CcSEcCtD
Histamine Phosphate—Skin disorder—Docetaxel—head and neck cancer	0.000712	0.00238	CcSEcCtD
Histamine Phosphate—Anorexia—Docetaxel—head and neck cancer	0.000699	0.00234	CcSEcCtD
Histamine Phosphate—Diarrhoea—Fluorouracil—head and neck cancer	0.000695	0.00232	CcSEcCtD
Histamine Phosphate—SLC22A5—saliva-secreting gland—head and neck cancer	0.000692	0.0215	CbGeAlD
Histamine Phosphate—Hypotension—Docetaxel—head and neck cancer	0.000685	0.00229	CcSEcCtD
Histamine Phosphate—Dizziness—Fluorouracil—head and neck cancer	0.000672	0.00225	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000668	0.00223	CcSEcCtD
Histamine Phosphate—Insomnia—Docetaxel—head and neck cancer	0.000663	0.00222	CcSEcCtD
Histamine Phosphate—Paraesthesia—Docetaxel—head and neck cancer	0.000658	0.0022	CcSEcCtD
Histamine Phosphate—CA4—trachea—head and neck cancer	0.000654	0.0203	CbGeAlD
Histamine Phosphate—Dyspnoea—Docetaxel—head and neck cancer	0.000654	0.00219	CcSEcCtD
Histamine Phosphate—Vomiting—Fluorouracil—head and neck cancer	0.000646	0.00216	CcSEcCtD
Histamine Phosphate—Dyspepsia—Docetaxel—head and neck cancer	0.000645	0.00216	CcSEcCtD
Histamine Phosphate—Rash—Fluorouracil—head and neck cancer	0.00064	0.00214	CcSEcCtD
Histamine Phosphate—Dermatitis—Fluorouracil—head and neck cancer	0.00064	0.00214	CcSEcCtD
Histamine Phosphate—Decreased appetite—Docetaxel—head and neck cancer	0.000637	0.00213	CcSEcCtD
Histamine Phosphate—Headache—Fluorouracil—head and neck cancer	0.000636	0.00213	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000633	0.00212	CcSEcCtD
Histamine Phosphate—Fatigue—Docetaxel—head and neck cancer	0.000632	0.00211	CcSEcCtD
Histamine Phosphate—Constipation—Docetaxel—head and neck cancer	0.000627	0.0021	CcSEcCtD
Histamine Phosphate—Pain—Docetaxel—head and neck cancer	0.000627	0.0021	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Docetaxel—head and neck cancer	0.000604	0.00202	CcSEcCtD
Histamine Phosphate—Nausea—Fluorouracil—head and neck cancer	0.000603	0.00202	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000599	0.002	CcSEcCtD
Histamine Phosphate—HRH2—lymph node—head and neck cancer	0.000586	0.0182	CbGeAlD
Histamine Phosphate—SLC22A3—thyroid gland—head and neck cancer	0.00058	0.0181	CbGeAlD
Histamine Phosphate—Body temperature increased—Docetaxel—head and neck cancer	0.00058	0.00194	CcSEcCtD
Histamine Phosphate—Abdominal pain—Docetaxel—head and neck cancer	0.00058	0.00194	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Docetaxel—head and neck cancer	0.00054	0.00181	CcSEcCtD
Histamine Phosphate—HRH1—connective tissue—head and neck cancer	0.000539	0.0168	CbGeAlD
Histamine Phosphate—SLC22A1—head—head and neck cancer	0.000539	0.0168	CbGeAlD
Histamine Phosphate—SLC22A5—trachea—head and neck cancer	0.000533	0.0166	CbGeAlD
Histamine Phosphate—Asthenia—Docetaxel—head and neck cancer	0.000526	0.00176	CcSEcCtD
Histamine Phosphate—Pruritus—Docetaxel—head and neck cancer	0.000519	0.00173	CcSEcCtD
Histamine Phosphate—CA4—thyroid gland—head and neck cancer	0.000517	0.0161	CbGeAlD
Histamine Phosphate—SLC22A3—head—head and neck cancer	0.000515	0.016	CbGeAlD
Histamine Phosphate—HRH1—epithelium—head and neck cancer	0.000512	0.0159	CbGeAlD
Histamine Phosphate—Diarrhoea—Docetaxel—head and neck cancer	0.000502	0.00168	CcSEcCtD
Histamine Phosphate—Dizziness—Docetaxel—head and neck cancer	0.000485	0.00162	CcSEcCtD
Histamine Phosphate—Vomiting—Docetaxel—head and neck cancer	0.000466	0.00156	CcSEcCtD
Histamine Phosphate—Rash—Docetaxel—head and neck cancer	0.000462	0.00155	CcSEcCtD
Histamine Phosphate—Dermatitis—Docetaxel—head and neck cancer	0.000462	0.00154	CcSEcCtD
Histamine Phosphate—Headache—Docetaxel—head and neck cancer	0.000459	0.00154	CcSEcCtD
Histamine Phosphate—CA4—head—head and neck cancer	0.000459	0.0143	CbGeAlD
Histamine Phosphate—HRH1—trachea—head and neck cancer	0.000452	0.0141	CbGeAlD
Histamine Phosphate—Nausea—Docetaxel—head and neck cancer	0.000435	0.00146	CcSEcCtD
Histamine Phosphate—SLC22A5—thyroid gland—head and neck cancer	0.000422	0.0131	CbGeAlD
Histamine Phosphate—SLC22A3—lymph node—head and neck cancer	0.000361	0.0112	CbGeAlD
Histamine Phosphate—CA4—lymph node—head and neck cancer	0.000321	0.01	CbGeAlD
Histamine Phosphate—HRH1—head—head and neck cancer	0.000318	0.00988	CbGeAlD
Histamine Phosphate—SLC22A5—lymph node—head and neck cancer	0.000262	0.00815	CbGeAlD
Histamine Phosphate—CYP2D6—head—head and neck cancer	0.000242	0.00752	CbGeAlD
Histamine Phosphate—HRH1—lymph node—head and neck cancer	0.000222	0.00692	CbGeAlD
